1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
9
BGF World Healthscience A2
Fee
2.17%
ISIN
LU0122379950
Holdings
10
We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with BGF World Healthscience, we have 20 holdings where UnitedHealth is the largest holding (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and BGF World Healthscience.
| UBS Lux Equity Fund Biotech USD | BGF World Healthscience |
|---|---|
|
10.04 % |
 8.2 % |
|
9.21 % |
7.01 % |
|
8.44 % |
 6.67 % |
|
8.08 % |
 3.99 % |
|
4.91 % |
3.67 % |
|
4.66 % |
3.61 % |
|
4.43 % |
3.58 % |
|
4.13 % |
 3.05 % |
|
3.75 % |
3.02 % |
| - |
  2.98 % |
The list of fund holdings was last updated on July 25, 2025.
